PHIO PHARMACEUTICALS CORP (PHIO)

US71880W4024 - Common Stock

0.75  -0.01 (-1.32%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.0020.00K
Operating Expenses
10.70M11.46M13.51M8.79M9.01M
Research and Development
6.33M7.01M8.89M4.43M4.30M
Selling, General, and Administrative Expenses
4.37M4.45M4.63M4.36M4.71M
Operating Income
-10.70M-11.46M-13.51M-8.79M-8.99M
Interest Income/Expense
N/AN/A-10.00KN/AN/A
Other Income/Expense
-2.00K-20.00KN/A0.0080.00K
Non Recurring Items
-126.00KN/A230.00KN/AN/A
Income Before Taxes
-10.83M-11.48M-13.29M-8.79M-8.91M
Income Tax
0.000.000.000.000.00
Net Income
-10.83M-11.48M-13.29M-8.79M-8.91M
EBITDA
-10.64M-11.39M-13.43M-8.72M-8.92M
 
Per Share Data
EPS Diluted Total Ops
-5.20-10.07-12.43-23.13-222.75
Non GAAP EPS
N/A-10.08N/AN/AN/A
 
Statistics
Profit Margin
N/AN/AN/AN/A-44550.00%
Operating Profit Margin
N/AN/AN/AN/A-44950.00%

All data in USD

Charts